Nephrocare Health Services Ltd.

NSE: NEPHROPLUS | BSE: 544647 | ISIN: INE428V01029 | Industry: Healthcare Services
|
746.0000 12.25 (1.67%)
NSE Jun 22, 2026 11:28 AM
Volume: 63,786
 

746.00
1.67%
ICICI Direct
Time tested dialysis chain model with high potential From one clinic in 2010 to 468 clinics in 2026, Nephrocare has come a long way to establish itself as one of the fastest growing healthcare providers with focus on dialysis care. Chronic Kidney Disease (CKD) has emerged as an important chronic disease in India due to growing diabetes and hypertension instances. However, only 15% of the CKD patients have access to dialysis (only cure besides kidney transplant) due to constraints such as accessibility and affordability. To cater to the unmet needs, India needs to nearly double the...
ICICI Direct released a Buy report for Nephrocare Health Services Ltd. with a price target of 900.0 on 18 Jun, 2026.
More from Nephrocare Health Services Ltd.
Recommended